World Health Organization recommends the use of bedaquiline in all conventional multidrug-resistant tuberculosis treatment regimens
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news
More News: Bedaquiline | International Medicine & Public Health | Multidrug Resistance | Pharmaceuticals | Tuberculosis | WHO